SAGE250117P25000
- 10.00
- 0.000.00%
Sage Therapeutics Newsroom
Biogen (BIIB.US) plans to acquire the remaining shares of Sage (SAGE.US) at a 30% premium.
Biogen (BIIB.US) will acquire the outstanding shares of Sage Therapeutics (SAGE.US) at a price of $7.22 per share.
Biogen Proposes Acquisition of Partner Sage Therapeutics
Biogen Bid For Sage Therapeutics Could Strengthen Neurology Strategy: Analysts
SAGE Therapeutics Up Over 39%, on Pace for Largest Percent Increase Since January 2019 -- Data Talk
Sage Therapeutics Shares Are Trading Higher After the Company Confirmed the Receipt of an Unsolicited, Nonbinding Proposal From Biogen to Acquire All Outstanding Shares Not Already Owned by Biogen for $7.22 per Share.
Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
U.S. Stock Market Early Session | U.S. stocks continue to be volatile, with technology stocks generally declining, NVIDIA down nearly 3%; Donald Trump concept stocks and some Chinese concept stocks are rising against the trend, DJT up nearly 9%, NetEase u
The rise in USA Treasury yields has led to continued selling of the large Technology stocks that have been leading the bull market over the past year. This week, the market is focusing on the upcoming Earnings Reports from several large Banks.
Biogen Wants to Buy Its Partner Sage for Almost No Premium -- Barrons.com
Why Is Depression-Focused Sage Therapeutics Stock Surging Higher On Monday?
Sage Celebrates a Landmark 2024 With Multiple Honors in the Insurance Industry
Truist Financial Maintains Sage Therapeutics(SAGE.US) With Hold Rating
US stock outlook | Wall Street begins to discuss the possibility of interest rate hikes! The three major index futures collectively weakened; Intra-Cellular surged nearly 35% in pre-market trading! It will be acquired by Johnson & Johnson for billions.
Tesla fell 3% before the market opened, as the largest Retirement Fund in Europe liquidated its shares; the yield on the 10-year US Treasury is aiming for 5%! The Global bond market is in turmoil.
Top Premarket Gainers
SAGE Therapeutics Outlines 2025 Strategy and Acquisition Proposal
12 Health Care Stocks Moving In Monday's Pre-Market Session
Sage Shares Surge Premarket After Biogen Proposes Takeover
Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
Biggest Stock Movers Monday: ITCI, and SAGE
Express News | Sage Therapeutics Shares up 36.2% at $7.56 Premarket After Biogen Proposes to Buy Remaining Stake in Co for $7.22 Apiece